
“Biomonitoring is the next logical, critical step for us to take in addressing threats to public health.” – Sen. Deborah Ortiz, D-Sacramento, author of the California Biomonitoring Program, SB689

Lennar’s LEN stocks had sunk to $3.60 per share by mid-November despite restructuring and partnership with the financial firm CB Richard Ellis, headed by Richard Blum, a UC regent and husband of Sen. Dianne Feinstein, a principle sponsor of the Lennar-funded Proposition G.